XML 74 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($)
Total
Common stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
IPO
IPO
Common stock
IPO
Additional Paid-in Capital
Private Placement
Private Placement
Common stock
Private Placement
Additional Paid-in Capital
At-the-Market Sales Agreement
At-the-Market Sales Agreement
Common stock
At-the-Market Sales Agreement
Additional Paid-in Capital
Redeemable Convertible Preferred Stock
Temporary equity beginning balance at Dec. 31, 2023                             $ 132,722,000
Temporary equity beginning balance, shares at Dec. 31, 2023                             31,465,128
Beginning balance at Dec. 31, 2023 $ (173,396,000)   $ 8,142,000 $ 164,000 $ (181,702,000)                    
Beginning balance, shares at Dec. 31, 2023   1,673,314                          
Issuance of Series D redeemable convertible preferred stock, Value                             $ 169,458,000
Issuance of Series D redeemable convertible preferred stock, Shares                             49,713,402
Conversion of convertible promissory notes into Series D-1 redeemable convertible preferred stock, Value                             $ 40,651,000
Conversion of convertible promissory notes into Series D-1 redeemable convertible preferred stock, Share                             11,887,535
Issuance of common shares, Value           $ 207,249,000   $ 207,249,000 $ 9,858,000   $ 9,858,000        
Issuance of common shares             12,650,000     588,888          
Conversion of convertible preferred stock into common stock 342,831,000   342,831,000                       $ (342,831,000)
Conversion of convertible preferred stock into common stock, Share   20,854,632                         (93,066,065)
Issuance of common stock upon exercise of options 634,000   634,000                        
Issuance of common stock upon exercise of options, shares   83,203                          
Stock-based compensation expense 6,979,000   6,979,000                        
Unrealized gain on marketable securities 0                            
Foreign currency translation adjustment 81,000     81,000                      
Net loss (71,109,000)       (71,109,000)                    
Ending balance at Dec. 31, 2024 $ 323,127,000   575,693,000 245,000 (252,811,000)                    
Ending balance, shares at Dec. 31, 2024 35,850,037 35,850,037                          
Issuance of common shares, Value                       $ 17,091,000   $ 17,091,000  
Issuance of common shares                         1,400,000    
Issuance of common stock upon exercise of options $ 714,000   714,000                        
Issuance of common stock upon exercise of options, shares 136,871 136,871                          
Stock-based compensation expense $ 11,691,000   11,691,000                        
Unrealized gain on marketable securities 122,000     122,000                      
Foreign currency translation adjustment (89,000)     (89,000)                      
Net loss (80,605,000)       (80,605,000)                    
Temporary equity Ending balance at Dec. 31, 2025 0                            
Ending balance at Dec. 31, 2025 $ 272,051,000   $ 605,189,000 $ 278,000 $ (333,416,000)                    
Ending balance, shares at Dec. 31, 2025 37,386,908 37,386,908